Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Beate Binsack has worked on the following 19 EPO patent applications which have been published in the last five years:

EP11711598

FACTOR XII INHIBITORS FOR TREATING INTERSTITIAL LUNG DISEASE

IPC classification:
A61K 38/00, C07K 14/81
Applicant:
Justus Liebig University Giessen (Justus-Liebig-Universität Gießen)
Agent:
Beate Binsack, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP12175363

Therapeutic application of Kazal-type serine protease inhibitors

IPC classification:
A61K 38/57, A61K 47/48, A61P 7/02, C07K 14/81
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP12153341

Factor XII inhibitors for the treatment of neurological inflammatory disorders

IPC classification:
A61K 38/06, A61K 38/48, A61K 38/55, A61K 38/57, A61K 39/395, A61K 47/48, A61P 25/00, A61P 37/00
Applicant:
CSL Ltd.
Applicant:
CSL Behring GmbH
Applicant:
Julius-Maximilians-University of Wuerzburg (Universität Würzburg)
Applicant:
University of Münster (Westfälische Wilhelms-Universität Münster)
Agent:
Beate Binsack, CSL Behring GmbH
Status:
APPLICATION REFUSED
EP12707782

FACTOR XII INHIBITORS FOR THE ADMINISTRATION WITH MEDICAL PROCEDURES COMPRISING CONTACT WITH ARTIFICIAL SURFACES

IPC classification:
A61K 38/55, A61K 38/57, A61K 39/395, A61P 9/10, C07K 16/36
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP12707624

FACTOR XII INHIBITORS FOR THE TREATMENT OF SILENT BRAIN ISCHEMIA AND ISCHEMIA OF OTHER ORGANS

IPC classification:
A61K 38/55, A61K 38/57, A61K 39/395, A61K 49/00, A61P 9/10, C07K 16/36, G01N 33/50
Applicant:
CSL Behring GmbH
Applicant:
The General Hospital Corporation
Agent:
Beate Binsack, CSL Behring GmbH
Status:
PATENT GRANTED
EP12719993

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS

IPC classification:
A61K 31/727, A61K 35/16, A61K 38/57, A61P 1/00, A61P 7/02, A61P 9/06, A61P 9/12, A61P 11/08
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP12808401

USE OF C1-INHIBITOR FOR THE TREATMENT OF SECONDARY EDEMA OF THE CENTRAL NERVOUS SYSTEM

IPC classification:
A61K 38/57, A61P 7/10, A61P 9/10
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13701651

FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS

IPC classification:
A61K 38/06, A61K 38/48, A61K 38/55, A61K 38/57, A61K 39/395, A61K 47/48, A61P 25/00, A61P 37/00, C07K 14/00
Applicant:
CSL Ltd.
Applicant:
CSL Behring GmbH
Applicant:
Julius-Maximilians-University of Wuerzburg (Universität Würzburg)
Applicant:
University of Münster (Westfälische Wilhelms-Universität Münster)
Agent:
Beate Binsack, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP11733884

AN ANCESTRAL SERINE PROTEASE COAGULATION CASCADE EXERTS A NOVEL FUNCTION IN EARLY IMMUNE DEFENSE

IPC classification:
A61K 38/45, A61P 31/00
Applicant:
CSL Behring GmbH
Applicant:
Hansa Medical AB
Agent:
Beate Binsack, CSL Behring GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12761739

COMBINATION THERAPY USING IMMUNOGLOBULIN AND C1-INHIBITOR

IPC classification:
A61K 38/55, A61K 39/395, A61P 9/10
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13823892

A METHOD FOR POLISHING ALBUMIN

IPC classification:
A61K 38/38, C07K 1/16, C07K 14/76
Applicant:
CSL Ltd.
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13777203

A METHOD OF PURIFYING PROTEINS

IPC classification:
C07K 1/14, C07K 1/16, C07K 1/30, C07K 1/36, C07K 14/47, C07K 14/79
Applicant:
CSL Behring AG
Applicant:
CSL Behring LLC
Agent:
Beate Binsack, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP13851610

RECONSTITUTED HDL FORMULATION

IPC classification:
A61K 38/17, A61P 3/06
Applicant:
CSL Ltd.
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13861334

A METHOD OF PURIFYING THERAPEUTIC PROTEINS

IPC classification:
A61K 38/36, A61K 38/37, C07K 1/18, C07K 1/20, C07K 14/75, C07K 14/755
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP14707379

THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM

IPC classification:
A61K 38/57, A61P 43/00
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
PATENT GRANTED
EP14708308

TREATMENT AND PREVENTION OF REMOTE ISCHEMIA-REPERFUSION INJURY

IPC classification:
A61K 38/57, A61K 39/395, A61P 7/02
Applicant:
CSL Behring GmbH
Applicant:
University of Bern (Universität Bern)
Agent:
Beate Binsack, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP14808213

PROCESS FOR PREPARING APOLIPOPROTEIN A-I (APO A-I)

IPC classification:
A61K 31/685, A61K 31/688, A61K 38/17, A61P 3/06, C07K 1/14, C07K 1/30, C07K 1/34, C07K 1/36, C07K 14/775
Applicant:
CSL Ltd.
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP14739078

COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR

IPC classification:
A61K 31/4365, A61K 31/519, A61K 31/60, A61K 31/727, A61K 38/57, A61K 39/395, A61K 45/06, A61K 47/48
Applicant:
CSL Behring GmbH
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP14833626

CONTAMINANT REMOVAL METHOD

IPC classification:
A61K 38/16, C07K 1/34, C07K 1/36, C07K 14/775
Applicant:
CSL Ltd.
Agent:
Beate Binsack, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature